Williams Kristen reported tax withholding involving 8,528 shares of Pacira BioSciences, Inc. at $22.32 for −$190k on Jun 3, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Chief Administrative Officer
Chief Administrative Officer
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$190,344.96Shares × reported price
Shares traded
8,528Common Stock
Price per share
$22.32Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
177,321Direct
Trade date
Jun 3, 2026Tax withholding
Filed
Jun 5, 2026, 5:57 PM ET2-day reporting delay
Accession
0001628280-26-041330Code F · Transaction 98946
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 4, 2026Sell10,259$22.27−$228,467.93Trade 98947
2 transaction rows in this filing. Joint filers share the same rows.

PCRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PCRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +8.5%1w ago +5.7%1d ago −2.2%
Returns since7d +1.1%30d +12%90d180d1y

Footnotes in full

F1: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on September 10, 2025.